Literature DB >> 17610340

Direct and indirect costs attributable to alcohol consumption in Germany.

Alexander Konnopka1, Hans-Helmut König.   

Abstract

AIM: To estimate the direct and indirect costs of morbidity and mortality attributable to alcohol consumption in Germany from a societal perspective in 2002.
METHODS: Using the concept of attributable risks and the prevalence-based approach, age- and gender-specific alcohol-attributable fractions for morbidity and mortality were calculated for alcoholic disorder, neoplasms, endocrinological, nervous, circulatory, digestive, skin and perinatal disorders, and injuries and poisonings. The literature provided data on alcohol consumption in Germany by age, gender and dose amount, and relative risks. Direct costs were calculated based on routine resource utilisation and expenditure statistics. Indirect costs were calculated based on the human capital approach using a discount rate of 5%.
RESULTS: Alcohol consumption accounted for 5.5% of all deaths and 970,000 years of potential life lost. Total costs were euro24,398 million, amounting to 1.16% of Germany's GDP, or euro296 per person. Direct medical and non-medical costs were euro8441 million. Indirect costs were euro15,957 million (69% mortality and 31% morbidity costs). In contrast, protective health effects of alcohol consumption saved euro4839 million.
CONCLUSIONS: The magnitude of alcohol-attributable morbidity and mortality and associated costs demands more preventive efforts.

Entities:  

Mesh:

Year:  2007        PMID: 17610340     DOI: 10.2165/00019053-200725070-00006

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  13 in total

1.  Economic cost of alcohol and drug abuse in the United States, 1992: a report.

Authors:  H J Harwood; D Fountain; G Fountain
Journal:  Addiction       Date:  1999-05       Impact factor: 6.526

2.  The relative risks and etiologic fractions of different causes of death and disease attributable to alcohol, tobacco and illicit drug use in Canada.

Authors:  E Single; J Rehm; L Robson; M V Truong
Journal:  CMAJ       Date:  2000-06-13       Impact factor: 8.262

3.  Alcoholism. The cost of illness in the Federal Republic of Germany.

Authors:  J G Brecht; F Poldrugo; P K Schädlich
Journal:  Pharmacoeconomics       Date:  1996-11       Impact factor: 4.981

4.  The economic costs to New Zealand of lost production due to alcohol abuse.

Authors:  J Chetwynd; T Rayner
Journal:  N Z Med J       Date:  1985-08-28

5.  The annual societal cost of alcohol misuse in Scotland.

Authors:  Susan J Varney; Julian F Guest
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

6.  Estimating the cost of illness.

Authors:  D P Rice
Journal:  Am J Public Health Nations Health       Date:  1967-03

7.  The social costs of alcohol abuse in New Zealand.

Authors:  N J Devlin; P A Scuffham; L J Bunt
Journal:  Addiction       Date:  1997-11       Impact factor: 6.526

Review 8.  The relationship of average volume of alcohol consumption and patterns of drinking to burden of disease: an overview.

Authors:  Jürgen Rehm; Robin Room; Kathryn Graham; Maristela Monteiro; Gerhard Gmel; Christopher T Sempos
Journal:  Addiction       Date:  2003-09       Impact factor: 6.526

9.  The social cost of alcohol, tobacco and illicit drugs in France, 1997.

Authors:  Philippe Fenoglio; Véronique Parel; Pierre Kopp
Journal:  Eur Addict Res       Date:  2003-01       Impact factor: 3.015

10.  The economic costs of illness: a replication and update.

Authors:  D P Rice; T A Hodgson; A N Kopstein
Journal:  Health Care Financ Rev       Date:  1985
View more
  15 in total

1.  [Addiction counselling in the surgical emergency room. Implementation of a brief intervention for alcohol-intoxicated patients].

Authors:  J Röhrig; M Nafz; P C Strohm; J Bengel; T Hodel; S Wahl; M Berner
Journal:  Unfallchirurg       Date:  2013-07       Impact factor: 1.000

2.  [Economic aspects of prevention].

Authors:  H H König; S Riedel-Heller
Journal:  Internist (Berl)       Date:  2008-02       Impact factor: 0.743

3.  Social cost of heavy drinking and alcohol dependence in high-income countries.

Authors:  Satya Mohapatra; Jayadeep Patra; Svetlana Popova; Amy Duhig; Jürgen Rehm
Journal:  Int J Public Health       Date:  2009-12-19       Impact factor: 3.380

4.  The costs of hazardous alcohol consumption in Germany.

Authors:  Tobias Effertz; Frank Verheyen; Roland Linder
Journal:  Eur J Health Econ       Date:  2016-08-20

5.  Health burden and costs of obesity and overweight in Germany.

Authors:  A Konnopka; M Bödemann; H-H König
Journal:  Eur J Health Econ       Date:  2010-04-18

6.  What are the Economic Costs to Society Attributable to Alcohol Use? A Systematic Review and Modelling Study.

Authors:  Jakob Manthey; Syed Ahmed Hassan; Sinclair Carr; Carolin Kilian; Sören Kuitunen-Paul; Jürgen Rehm
Journal:  Pharmacoeconomics       Date:  2021-05-10       Impact factor: 4.981

7.  Methods for Estimating Avoidable Costs of Excessive Alcohol Consumption.

Authors:  Beata Gavurova; Miriama Tarhanicova
Journal:  Int J Environ Res Public Health       Date:  2021-05-07       Impact factor: 3.390

8.  Do Costs in the Education Sector Matter? A Systematic Literature Review of the Economic Impact of Psychosocial Problems on the Education Sector.

Authors:  Irina Pokhilenko; Luca M M Janssen; Silvia M A A Evers; Ruben M W A Drost; Lena Schnitzler; Aggie T G Paulus
Journal:  Pharmacoeconomics       Date:  2021-06-14       Impact factor: 4.981

Review 9.  The economic impact of alcohol consumption: a systematic review.

Authors:  Montarat Thavorncharoensap; Yot Teerawattananon; Jomkwan Yothasamut; Chanida Lertpitakpong; Usa Chaikledkaew
Journal:  Subst Abuse Treat Prev Policy       Date:  2009-11-25

10.  Risk profiles of treatment noncompletion for inpatients and outpatients undergoing alcohol disorder rehabilitation treatment.

Authors:  Ulrich W Preuss; Jörg Zimmermann; Gabriele Schultz; Anna Watzke; Peggy Schmidt; Bärbel Löhnert; Michael Soyka
Journal:  Subst Abuse Rehabil       Date:  2012-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.